Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 3/20 | 0.36 |
| ▸ | CDK2 | P24941 | 4/20 | 0.33 |
| ▸ | PYGL | P06737 | 3/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 3/20 | 0.32 |
| ▸ | GSK3B | P49841 | 3/20 | 0.32 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.32 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.32 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | IGF1R | P08069 | 1/20 | 0.31 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.30 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953027 | 0.92 | IL17A (0.37) | IL17APYGLMAPK14IGF1R | |
| SCHEMBL30952940 | 0.88 | IL17A (0.39) | IL17ACDK2CCNE1GSK3BTAS1R3 | |
| SCHEMBL30953083 | 0.86 | IL17A (0.34) | IL17ACDK2CCNE1GSK3BTAS1R3 | |
| SCHEMBL30953026 | 0.86 | IL17A (0.41) | IL17APYGLIGF1R | |
| SCHEMBL30952928 | 0.85 | IL17A (0.41) | IL17APYGL | |
| SCHEMBL30953012 | 0.85 | IL17A (0.38) | IL17APYGL | |
| SCHEMBL30953067 | 0.84 | IL17A (0.48) | IL17APYGL | |
| SCHEMBL30953308 | 0.84 | IL17A (0.33) | IL17ACDK2CCNE1GSK3B | |
| SCHEMBL30953347 | 0.83 | IGF1R (0.34) | IL17AGSK3BMAPK14IGF1R | |
| SCHEMBL30953483 | 0.83 | IGF1R (0.34) | IL17AGSK3BMAPK14IGF1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | claimed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | claimed |
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |